VivoSense Marks Rare Disease Day

VivoSense recognizes Rare Disease Day by minding the importance of discovering new advancements in research and clinical trials to care for those with rare diseases. There are approximately 30 million Americans living with rare diseases today, and research into new therapies is imperative for these patients.

We are pleased to be currently assisting in clinical trials targeting respiratory therapies for rare diseases such as Rett Syndrome and Spinal Muscular Atrophy using wearable sensor solutions. We believe the use of wearable sensor technology for long-term monitoring of respiratory characteristics will open new doors for research in rare diseases.

For more information on Rare Disease Day, visit the National Organization for Rare Disorders.

National Organization for Rare Disorders | NORD

Dudley Tabakin

Dudley Tabakin

Dudley Tabakin, MSc. is Chief Product Officer and co-founder of VivoSense and a fervent believer in “good data” over “big data" in the development of digital endpoints from wearable sensor technology.

Follow on:

Stay Connected